Leap Therapeutics Inc (LPTX)
3.24
+0.05
(+1.57%)
USD |
NASDAQ |
May 06, 16:00
3.22
-0.02
(-0.62%)
After-Hours: 20:00
Leap Therapeutics Cash from Operations (Quarterly): -10.38M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.38M |
| September 30, 2023 | -10.49M |
| June 30, 2023 | -10.18M |
| March 31, 2023 | -12.70M |
| December 31, 2022 | -13.01M |
| September 30, 2022 | -12.25M |
| June 30, 2022 | -12.26M |
| March 31, 2022 | -11.52M |
| December 31, 2021 | -10.72M |
| September 30, 2021 | -8.102M |
| June 30, 2021 | -7.752M |
| March 31, 2021 | -8.587M |
| December 31, 2020 | -5.988M |
| September 30, 2020 | -6.592M |
| June 30, 2020 | -9.451M |
| March 31, 2020 | -3.926M |
| December 31, 2019 | -5.894M |
| September 30, 2019 | -6.957M |
| June 30, 2019 | -7.183M |
| March 31, 2019 | -6.868M |
| December 31, 2018 | -7.05M |
| September 30, 2018 | -7.452M |
| Date | Value |
|---|---|
| June 30, 2018 | -6.053M |
| March 31, 2018 | -5.478M |
| December 31, 2017 | -6.369M |
| September 30, 2017 | -2.357M |
| June 30, 2017 | -7.062M |
| March 31, 2017 | -6.349M |
| December 31, 2016 | -7.297M |
| September 30, 2016 | -7.371M |
| June 30, 2016 | -6.536M |
| March 31, 2016 | -4.133M |
| December 31, 2015 | 8.544M |
| September 30, 2015 | -5.362M |
| June 30, 2015 | -5.642M |
| March 31, 2015 | -5.642M |
| December 31, 2014 | -5.649M |
| September 30, 2014 | -5.113M |
| June 30, 2014 | -4.318M |
| March 31, 2014 | -2.937M |
| December 31, 2013 | -3.796M |
| September 30, 2013 | -1.939M |
| June 30, 2013 | -2.404M |
| March 31, 2013 | -1.80M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.01M
Minimum
Dec 2022
-3.926M
Maximum
Mar 2020
-9.155M
Average
-9.451M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| Cutera Inc | -33.77M |
| OrthoPediatrics Corp | -7.543M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -43.75M |
| Free Cash Flow Per Share (Quarterly) | -0.3836 |
| Free Cash Flow Yield | -66.12% |